CARCINOMA, ADRENOCORTICAL
Clinical trials for CARCINOMA, ADRENOCORTICAL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, ADRENOCORTICAL trials appear
Sign up with your email to follow new studies for CARCINOMA, ADRENOCORTICAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug target for rare cancers enters human testing
Disease control Recruiting nowThis early-phase trial tests a new drug called ADCT-701 in adults with rare cancers of the digestive tract, pancreas, lungs, or adrenal glands. The main goal is to find the safest dose and see if the drug can shrink tumors. Participants receive the drug through an IV every 3 week…
Matched conditions: CARCINOMA, ADRENOCORTICAL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New radiation approach before surgery for rare adrenal cancer shows promise
Disease control Recruiting nowThis early-phase trial tests giving radiation therapy before surgery for people whose adrenal cancer has come back. The goal is to find the safest radiation dose and see if it helps shrink tumors before removal. About 32 adults with recurrent but operable adrenal cancer will rece…
Matched conditions: CARCINOMA, ADRENOCORTICAL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC